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Abstract 
Background and Objective: Keratinization of the oral mucosa, such as the gingiva, has 
been shown to be important for periodontal health. Caspase-14 is a protease that plays 
a role in keratinization of the epidermis. The objective of this study was to investigate 
whether the expression of caspase-14 is intimately linked with keratinization and to 
examine the effect of the main component of green tea on the improvement of 
keratinization in rat oral mucosal preparations. 
 
Materials and Methods: Histological and immunohistochemical analyses and 
quantitative mRNA measurements of caspase-14 and its substrate filaggrin were 
performed using different types of rat epithelial tissue and organotypic reconstruction 
culture models derived from epithelial cells and fibroblasts taken from the rat oral 
mucosa.  
 
Results: In the skin, palate, buccal mucosa, and esophagus, the degree of keratinization 
appeared to be associated with cytokeratin 10 expression. The relative protein and 
mRNA expression levels of caspase-14 and filaggrin were consistent with the degree of 
keratinization in the following order: skin > palate > buccal mucosa > esophagus. The 
culture models of palatal and buccal mucosa retained a stratified epithelial structure. 
Caspase-14 expression appeared to be greater in the palatal model than in the buccal 
model. Remarkably, epigallocatechin-3-gallate (EGCG) improved the localization of 
cytokeratins and increased caspase-14 and filaggrin expression. This expression was 
more intense in the palatal model than in the buccal model, indicating that both models 
maintain the intrinsic properties of keratinization of the mucosa from where the 
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cultured cells were derived.  
 
Conclusions: These results suggest that keratinization is closely associated with 
caspase-14 and filaggrin expression. Our reconstruction models are promising tools for 
drug evaluation and show that EGCG is beneficial for improving both keratinization 
and the expression of the linked protease in the oral mucosa. 
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Introduction 
Epithelial tissue protects internal tissues against exogenous physical, chemical, 
and microbiological damage by forming a barrier between the body and the environment 
and also protects against dehydration (1). In the upper layers of some types of stratified 
epithelia, such as the epidermis, the cells are dead, contain no nucleus, and are 
surrounded by a cornified envelope to form an epithelial barrier (2). Conversely, in 
non-keratinized epithelial tissues, including the buccal mucosa of the human oral cavity, 
the cells are not flattened and still contain a nucleus. Several clinical studies have 
indicated that in some periodontal regions, the keratinized epithelium plays a role in 
stabilizing the mucosa; an adequate width of keratinized epithelium is likely to be 
important for sustainable gingival health (3,4), and the absence of keratinized mucosa 
around endosseous dental implants might increase the susceptibility of the peri-implant 
region to plaque-induced tissue destruction (5–7).  
Caspase-14 belongs to the family of aspartate-specific proteinases and is expressed 
in the epidermal epithelia, which is involved in keratinization and barrier formation 
(8–10). Previous reports have demonstrated that its transcription is upregulated by the 
green tea polyphenol epigallocatechin-3-gallate (EGCG) (11,12). One of the substrates of 
active caspase-14 is filaggrin, which plays a role in tissue hydration after its 
degradation into free hygroscopic amino acids (1,13). These findings underscore the 
importance of caspase-14 in the formation of the epidermal barrier (9,10,14). 
Caspase-14 is reportedly not expressed in the non-keratinized keratinocytes of the oral 
cavity (15); nevertheless, previous studies have paid little attention to the involvement 
of caspase-14 and filaggrin in the degree of keratinization in distinct regions of the oral 
cavity.  
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We hypothesized that the differential expression of caspase-14 may be intimately 
connected with keratinization of the oral mucosa. Generally, the pattern of 
keratinization in experimental animals should be considered with caution because of 
species differences. Nevertheless, in vivo and in vitro models derived from the same 
animal are useful for quantitatively comparing the relationship between the degree of 
keratinization and the expression of the related protease and its substrate. In the 
present study, instead of using gingival epithelium due to its insufficient size, we 
dissected distinct areas of neonatal rat oral mucosa in which different degrees of 
keratinization can be expected. We then compared the expression of caspase-14 and 
filaggrin in in vivo preparations of the oral mucosa with preparations of epidermal and 
esophageal epithelia. Next, we produced organotypic culture models using epithelial 
cells and fibroblasts dissociated from the regions used in the in vivo studies to examine 
whether phenotypic differences exist between these models with respect to 
keratinization and the distribution of caspase-14. Furthermore, we used these models to 
investigate the potential of EGCG for improving keratinization and the expression of 
caspase-14 and filaggrin. Both models proved useful for evaluating various reagents 
used to improve keratinization of the oral mucosa. 
  
Materials and methods 
Antibodies and reagents  
The following primary antibodies were used: mouse monoclonal anti-cytokeratin 14 
(CK14) (1:100; Novocastra, Newcastle, UK), anti-CK13 (Ks13.1, Progen, Heidelberg, 
Germany) and anti-CK10 (1:100; Dako, Glostrup, Denmark), and rabbit polyclonal 
anti-caspase-14 (IMG-5713, 1:100; Imgenex, San Diego, CA) and anti-filaggrin (1:50; 
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Bioss, Woburn, MA). EGCG was purchased from Enzo Life Sciences (San Diego, CA). 
 
Histological and immunohistochemical examinations  
Neonatal Wistar rats (7 days old) were anesthetized with isoflurane and sacrificed. 
Permission for the procedures used was granted by the Animal Research Committee of 
Fukuoka Dental College (permission number, 11009). Three animals were used for each 
histological and immunohistochemical experiment. The in vivo rat tissues or 
reconstructed models were fixed in 10% formalin solution, processed routinely, and 
embedded in paraffin. Five-micrometer-thick sections were stained with hematoxylin 
and eosin (H-E). For 3,3′-diaminobenzidine visualization of immunostaining, the tissue 
sections were incubated in 10% normal goat serum, then incubated with primary 
antibodies for 3 h at 4 °C, followed by incubation for 1 h with the corresponding 
secondary antibodies conjugated with horseradish peroxidase at room temperature. The 
sections were counterstained with hematoxylin. Quantification of the relative area of 
immunostaining was performed with the aid of ImageJ software (NIH, Bethesda, MD). 
 
Real-time PCR measurement of mRNA levels 
Rat tissues and the reconstitution models were dissected and dispersed in an RNA 
extraction reagent (Sepasol-RNA I SuperG; Nacalai Tesque, Kyoto, Japan) by using a 
homogenizer (Dispergieantrieb T10 Basic; IKA Japan K.K., Osaka, Japan). Total RNA 
was isolated and the mRNA was reverse transcribed into cDNA using a PrimeScript RT 
Reagent Kit (Takara Bio, Shiga, Japan) according to the manufacturer’s instructions. 
Quantitative PCR (qPCR) was performed on an Applied Biosystems 7500 Real-time 
PCR system (Grand Island, NY) using SYBRR Premix Ex Taq II (Takara Bio) and a pair 
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of specific primers to target rat caspase-14 (forward: 
5′-CCTGGAGATGAACTTGCTGTG-3′, reverse: 5′-CTTCTTCCGGAGGGTGCTTTG-3′, 
GenBank accession number: NM_001191776) and profilaggrin (forward: 
5′-ATGCTAGATGTGGACCACGATGAC-3′, reverse: 
5′-TGTTCCCTCTTCCTCTTGGGCTT-3′, GenBank accession number: XM_003753631) 
under the thermal cycling conditions recommended by the manufacturer. qPCR was 
performed on the samples in duplicate. A standard curve was used to calculate the 
expression of caspase-14 and profilaggrin normalized to the endogenous control GAPDH 
(forward: 5′-GACATGCCGCCTGGAGAAAC-3′, reverse: 
5′-AGCCCAGGATGCCCTTTAGT-3′, GenBank accession number: NM_017008), and 
their relative levels were compared.  
 
Construction of rat oral mucosal models using collagen gel matrix culture  
All procedures were conducted based on previous studies using skin (16–19) and oral 
mucosa (17,20). Oral mucosa samples were dissected from the palatal and buccal 
regions of 7-day-old rats (approximately 3.0 mm × 3.0 mm for the palate and 1.5 mm × 
2.0 mm for the buccal mucosa) and incubated overnight at 4 °C in modified Eagle’s 
medium (MEM) containing dispase (750 protease units/mL; Dispase II; Godo Shusei, 
Tokyo, Japan). Epithelial tissue was peeled and digested at 37 °C for 5 min in 
phosphate-buffered saline containing 0.1% trypsin solution and 0.65 mM EDTA (Gibco, 
Grand Island, NY). The cells were resuspended in MCDB 153 medium (Kinousei 
Peptide Institute, Yamagata, Japan). The mucosal lamina propria was minced into 
rectangular pieces and cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
containing 10% fetal bovine serum (FBS). After fibroblasts had sprouted from the tissue, 
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the cells were cultured in fresh medium containing 10% FBS. The fibroblasts were 
cultured for 5–6 days and then subcultured 2 or 3 times.  
Collagen gels were prepared on ice by mixing type I collagen (0.7 volume; Nitta 
Gelatin, Osaka, Japan) with a reconstitution buffer (0.1 volume; 2.2 g NaHCO3 and 4.77 
g HEPES in 100 mL of a 50 mM NaOH solution, pH 7.0), and 5-times concentrated 
DMEM (0.2 volume). Three milliliters of the gel mixed with 2.0 × 106 dermal fibroblasts 
was poured into a cell culture insert (2.5 cm diameter; Millicell CM; Millipore, Billerica, 
MA). The gel was solidified by warming at 37 °C for 30 min. Epithelial cells were 
overlaid on the collagen gel containing the fibroblasts. The culture insert was placed in 
an outer dish (10-cm diameter) containing MCDB 153 medium + DMEM (1:1) 
supplemented with 10% FBS and a growth factor cocktail (0.4% v/v bovine pituitary 
extract, 0.2 ng/mL human epidermal growth factor, 5 µg/mL transferrin, 5 µg/mL 
insulin, and 0.18 µg/mL hydrocortisone; Kurabo, Osaka, Japan), 250 µM ascorbic acid, 
and 20 µM phosphatidylethanolamine (Sigma-Aldrich, St. Louis, MO), and incubated at 
37 °C in 5% CO2. After the epithelial cells had grown to confluency, the gel surface was 
transferred to an air-liquid interface by removing the inner medium and reducing the 
amount of the outer medium to the level of the gel to avoid immersing or drying the 
surface of the gel (air-lift). Fresh culture medium was added every other day. The 
reconstruction models were used 8 days after air-lift. 
 
Statistical analysis 
Data are presented as the mean ± standard error of the mean (N, number of 
observations). Statistical analysis was performed using one-way analysis of variance 
(ANOVA) followed by a post-hoc test. A P value less than 0.05 was considered 
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statistically significant. 
 
Results 
Distinct profiles of keratinization and cytokeratin expression in rat epithelial tissues 
We performed histological examination of the four types of rat stratified epithelial 
tissues with H-E staining (Figure 1, H-E). In the skin samples, a remarkably high 
eosinophilic pattern was observed in the cornified layers, and their surface was often 
loosened and shed, probably due to the dehydration step before paraffin embedding. The 
epithelial cells within the granular layers appeared to be well flattened, and dense 
dot-like staining of keratohyalin granules was observed underneath the cornified layer 
(arrowhead). Judging from the eosinophilic staining of the palatal mucosa, a cornified 
layer was evident, but to a lesser degree than in the skin. The granular epithelial cells 
were also flattened, and fewer keratohyalin granules were observed than in the skin 
(arrowhead). The rat buccal mucosa also exhibited keratinization (superficial layer), 
and its epithelial-lamina propria junction was scalloped, showing connective tissue 
papillae and rete ridges. It contained thicker epithelial intermediate layers compared 
with the other three specimens and each cell was less flattened than in the skin. A few 
keratohyalin granules were scattered in the upper layers (arrowheads). In contrast, a 
cornified layer was faint in the esophagus. 
Pairs of cytokeratins are known to be region-specific; for instance, CK5 and CK14 in 
the basal layer, CK1 and CK10 in the suprabasal layer accompanied with 
orthokeratinization, and CK4 and CK13 in the suprabasal layer in non-keratinized 
epithelium (21). Thus, we compared cytokeratin expression by immunohistochemistry. 
Initially, we confirmed that no positive staining was observed in the absence of the 
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primary antibodies used. The anti-CK10 antibody exhibited intense immunostaining of 
the granular and spinous layers of the skin (Figure 1, CK10). In the palate, it elicited 
strong immunoreactivity in the spinous layer and moderate staining in the granular 
layer, whereas its immunoreactivity was almost lost in the esophagus. In the buccal 
mucosa, immunostaining with the anti-CK10 antibody was mottled in the intermediate 
area.  
In marked contrast, the anti-CK13 antibody demonstrated a consistent pattern of 
suprabasal staining in the esophageal samples, whereas moderate staining was 
observed in the buccal samples (Figure 1, CK13). Specific staining was almost lost in 
the skin and palatal samples. The anti-CK14 antibody exhibited consistent staining in 
the basal and parabasal layers of the skin and in all mucosa samples (Figure 1, CK14). 
These results suggest that the degree of keratinization is well correlated with the 
expression of CK10 in different types of mucosal epithelia and the epidermis.  
 
Expression of caspase-14 and filaggrin in rat stratified epithelial tissues 
Intense caspase-14 staining was observed in the granular and spinous layers of the 
skin and in the spinous layer of the palate (Figure 2A). Caspase-14 staining was 
broader in the intermediate layer of the buccal mucosa and only slight staining was 
observed in the esophageal mucosa. The antibody to filaggrin recognized the granular 
layers, but not the cornified layers, of the skin and palatal mucosa, whereas it exhibited 
weak staining in the buccal mucosa and only slight staining in esophagus. Figure 2B 
shows the quantitative analysis of the immunostaining of caspase-14 and filaggrin from 
four preparations. The relative values for the immunoreactive areas of caspase-14 and 
filaggrin were in the following descending order: skin > palate > buccal mucosa > 
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esophagus. Real-time PCR analysis demonstrated that the mRNA levels of caspase-14 
and profilaggrin were also in the same descending order (Figure 3).  
 
Organotypic reconstruction models of rat oral mucosa: EGCG-induced acceleration of 
keratinization and caspase-14 and filaggrin expression  
Next, we tested the expression of cytokeratins, caspase-14, and filaggrin during 
keratinization by using reconstruction models (8 days after air-lift) derived from 
epithelial cells and fibroblasts from the palatal and buccal mucosa of neonatal rats. The 
culture models retained a multilayered epithelial structure. However, the 
epithelial-collagen gel (including fibroblasts) junction was parallel to the surface of the 
models, which was different from the irregular junction observed in the in vivo buccal 
mucosa. Epithelial differentiation was not as pronounced as in the in vivo samples 
according to the degree of keratinization and the expression of CK14 and CK10 (Figure 
4, EGCG(-)). Under these conditions, caspase-14 expression appeared to be greater in 
the palatal model than in the buccal model. Previously, EGCG was reported to 
upregulate caspase-14 and filaggrin expression (11,12,22). In the present reconstruction 
models, 100 µM EGCG significantly increased the expression of caspase-14 and 
filaggrin, especially in the palate (Figure 4, EGCG(+)). Furthermore, EGCG promoted 
keratinization, while localizing the expression of CK14 and CK10 to the basal and 
suprabasal layers, respectively (Figure 4). The expression of caspase-14, filaggrin, and 
cytokeratins and the degree of keratinization were observed to a greater extent in the 
palatal model compared with the buccal model (Figure 4). 
 
Discussion 
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Epithelial tissue is important for protecting the underlying tissues from 
environmental damage, and the oral cavity is not considered an exception, while a 
remarkable degree of regional variation is found with respect to keratinization in 
various types of epithelial tissues (1,23,24). In the present study, we investigated the 
morphology and keratinization patterns of four types of rat stratified epithelia to 
identify possible differences among these tissues. In general, CK10 is known to be a 
specific marker for the terminal differentiation of the epidermis (21). The present study, 
using neonatal rat tissues, showed that CK10 expression was intense in the skin and 
palatal mucosa, which appeared to be orthokeratinized. Notably, the rat buccal mucosa 
is likely to have an intermediate characteristic of non-keratinized and keratinized 
epithelia. In fact, in the rat buccal mucosa, CK13, which is found predominantly in 
human non-keratinized epithelium (21), was present; yet the scattered expression of 
CK10 and the presence of keratohyalin granules were also observed. In humans, no 
keratinization or CK10 protein expression has been observed in the buccal mucosa (17), 
even though CK10 mRNA has been found in normal buccal mucosa with a much wider 
range of expression than CK10 protein (25). These observations denote the species 
differences in keratinization and cytokeratin expression in oral tissues. The present 
findings indicate that the distinct patterns of keratinization and cytokeratin expression 
in the oral cavity are likely to play an important role in site-specific protection from 
physical damage, although it is not yet well understood how such patterns are made.  
This study demonstrated that the highest levels of caspase-14 mRNA and protein 
expression are in the skin, while the lowest levels are in the esophagus. Furthermore, 
expression to an intermediate extent was observed in the palatal and buccal tissues. 
Lippens et al. (15) reported that caspase-14 expression is absent in the human oral 
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epithelium. The present study revealed non-negligible levels of caspase-14 expression in 
the rat oral mucosa, being consistent with the degree of keratinization and the 
expression of CK10. Active caspase-14 cleaves filaggrin units into fragments (9); these 
degraded products are the major source of hygroscopic amino acids, which are 
important for maintaining hydration of the skin (13,14,26). Filaggrin protein expression 
was reported to be distributed in the oral epithelium of newborn rats (27). The present 
real-time PCR and immunostaining results clearly shows that profilaggrin 
transcription and filaggrin protein expression are well correlated with the expression of 
caspase-14. However, given the lack of human experimental data to corroborate the 
present results, further studies with human tissues are required to support the 
potential of the present findings in translational dentistry. 
The organotypic reconstruction models used in this study maintained the 
multilayered structure of the oral mucosa, even though epithelial differentiation 
appeared incomplete, as judged from the expression of cytokeratins. EGCG is known to 
be an activator of caspase-14 (11,12) and filaggrin (22) expression. In our reconstruction 
models, we found that EGCG markedly increased the expression of caspase-14 and 
filaggrin in accordance with the promotion of keratinization and localization of 
cytokeratins. The finding that immunoreactivity to CK10, caspase-14, and filaggrin was 
more pronounced in the palatal culture than in the buccal culture suggests that the 
organotypic models retain the intrinsic properties of keratinization of the mucosa from 
where the cultured cells were derived (17). These findings support the presence of a 
close relationship between caspase-14 expression and keratinization of the epithelium. 
In addition, we found that EGCG has the potential to augment keratinization of the 
epithelium. Accumulating evidence suggests that EGCG has the potential to have an 
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impact on a variety of human diseases as an anti-infective, anti-oxidative, 
anti-angiogenic, and anti-tumor agent (28–30). Furthermore, EGCG could have a 
beneficial effect on stabilizing the oral mucosa as keratinization has been shown to have 
an important role in maintaining healthy gingiva (3,4). Our model is a promising tool 
for analyzing the effects of various reagents on keratinization of the oral mucosa. For 
future clinical investigation of the effects of EGCG on keratinization, further 
experiments using human culture models are needed to confirm the link between 
caspase-14 and filaggrin. 
In conclusion, the rat oral mucosa contains keratinized epithelium, which is closely 
associated with the expression of caspase-14 and its substrate filaggrin. By using the 
reconstruction models to search for substances with the potential to induce 
keratinization, this study provides evidence that a component of green tea, EGCG, 
stimulates keratinization of the epithelium in the oral cavity, probably leading to the 
maintenance of sustainable oral health. 
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Figure legends 
Figure 1. Histological and immunohistochemical assessments of the skin, palate, buccal 
mucosa, and esophagus of rats. H-E, hematoxylin-eosin staining; B, basal layer; S, 
spinous layer; G, granular layer; C, cornified layer; I, intermediate layer; Su, superficial 
layer (1). Arrowheads denote keratohyalin granules. Anti-cytokeratin 10 (CK10), 13 
(CK13), and 14 (CK14) antibodies were used.  
 
Figure 2. Immunostaining using antibodies against caspase-14 and filaggrin in the skin, 
palate, buccal mucosa, and esophagus of rats. A, anti-caspase-14 and anti-filaggrin 
antibodies recognized stratified epithelium with a distinct pattern in these samples. B, 
quantitative analysis of the relative area of immunostaining for caspase-14 and 
filaggrin (n = 3 animals per group). *P < 0.05, **P < 0.01, ***P < 0.001; one-way ANOVA 
followed by post-hoc Fisher’s PLSD test. 
 
Figure 3. Expression of caspase-14 and profilaggrin mRNA in the skin, palate, buccal 
mucosa, and esophagus of rats. A, typical RT-PCR results obtained using cDNA derived 
from the 4 types of tissue using specific primer pairs for caspase-14, profilaggrin, and 
GAPDH. B, quantitative real-time PCR measurements of caspase-14 and profilaggrin 
mRNA in the distinct types of epithelium (n = 4 animals per group). Expression values 
were calculated by the relative standard curve method. **P < 0.01; one-way ANOVA 
followed by post-hoc Scheffe’s test. 
 
Figure 4. H-E staining and immunostaining in the reconstruction models using 
epithelial cells and fibroblasts dissociated from rat palatal and buccal mucosa. The 
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models were cultured in the presence (+) or absence (-) of 100 µM EGCG. A, anti-CK14, 
anti-CK10, anti-caspase-14, and anti-filaggrin antibodies recognized distinct patterns 
in the reconstruction models. B, quantitative analysis of the relative area of 
immunostaining for caspase-14 and filaggrin (n = 3). E(+) and E(-) denote the presence 
(+) or absence (-) of EGCG.*P < 0.05, **P < 0.01, ***P < 0.001; one-way ANOVA followed 
by post-hoc Fisher’s PLSD test. 
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